-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Cogent Biosciences, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2018 to Q1 2024.
- Cogent Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$52.5M, a 32.9% decline year-over-year.
- Cogent Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$208M, a 35.3% decline from 2023.
- Cogent Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$154M, a 29.5% decline from 2022.
- Cogent Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$119M, a 102% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)